Ragu P. Ratnakumaran

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Reply to Therese Kang and Wee Loon Ong's Letter to the Editor re: Ragu Ratnakumaran, Douglas H. Brand, Archana Sasitharan, et al. Exploring Factors Associated with Late Urinary Toxicity After Prostate Stereotactic Body Radiotherapy: Findings from the PACE-B Study. Eur Urol 2026;89:71-9.

Reply to Therese Kang and Wee Loon Ong's Letter to the Editor re: Ragu Ratnakumaran, Douglas H. Brand, Archana Sasitharan, et al. Exploring Factors Associated with Late Urinary Toxicity After Prostate Stereotactic Body Radiotherapy: Findings from the PACE-B Study. Eur Urol 2026;89:71-9.

Journal: European urology

Published: February 27, 2026

Exploring Factors Associated with Late Urinary Toxicity After Prostate Stereotactic Body Radiotherapy: Findings from the PACE-B Study.

Exploring Factors Associated with Late Urinary Toxicity After Prostate Stereotactic Body Radiotherapy: Findings from the PACE-B Study.

Journal: European urology

Published: March 21, 2025

HERMES: Randomized Trial of 2-Fraction or 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation Therapy.

HERMES: Randomized Trial of 2-Fraction or 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation Therapy.

Journal: International journal of radiation oncology, biology, physics

Published: January 23, 2025

Dosimetric Comparison of CyberKnife and Conventional Linac Prostate Stereotactic Body Radiation Therapy Plans: Analysis of the PACE-B Study.

Dosimetric Comparison of CyberKnife and Conventional Linac Prostate Stereotactic Body Radiation Therapy Plans: Analysis of the PACE-B Study.

Journal: International journal of radiation oncology, biology, physics

Published: October 17, 2024

Toxicity After Prostate Radiation Therapy: Addressing the Transurethral Resection of the Prostate (TURP) Challenge.

Toxicity After Prostate Radiation Therapy: Addressing the Transurethral Resection of the Prostate (TURP) Challenge.

Journal: International journal of radiation oncology, biology, physics

Published: June 28, 2024

Stereotactic Body Radiotherapy (SBRT) to Localised Prostate Cancer in the Era of MRI-Guided Adaptive Radiotherapy: Doses Delivered in the HERMES Trial Comparing Two- and Five-Fraction Treatments.

Stereotactic Body Radiotherapy (SBRT) to Localised Prostate Cancer in the Era of MRI-Guided Adaptive Radiotherapy: Doses Delivered in the HERMES Trial Comparing Two- and Five-Fraction Treatments.

Journal: Cancers

Published: April 28, 2024

Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicity.

Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicity.

Journal: Clinical and translational radiation oncology

Published: January 17, 2024

Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation Therapy.

Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation Therapy.

Journal: International journal of radiation oncology, biology, physics

Published: July 17, 2023

The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B Study.

The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B Study.

Journal: Cancers

Published: January 19, 2023

Patterns of Failure After Stereotactic Body Radiotherapy to Sacral Metastases.

Patterns of Failure After Stereotactic Body Radiotherapy to Sacral Metastases.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: December 16, 2022

The Management of Oligometastases in Non-small Cell Lung Cancer - is Stereotactic Ablative Radiotherapy now Standard of Care?

The Management of Oligometastases in Non-small Cell Lung Cancer - is Stereotactic Ablative Radiotherapy now Standard of Care?

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: July 12, 2022

Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated With Immune Checkpoint Inhibitor Therapy.

Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated With Immune Checkpoint Inhibitor Therapy.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

Published: October 01, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026